Results 191 to 196 of about 11,634 (196)

Glycoprotein IIb/IIIa inhibitors in the treatment of thromboembolic events related to endovascular treatment of cerebral aneurysms-systematic review and meta-analysis. [PDF]

Neuroradiol J
Hasanpour M, Maleki S, Rezaee H, Aminzadeh B, Abbasi Shaye Z, Keykhosravi E.   +5 more
europepmc   +1 more source

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation. [PDF]

Blood Vessel Thromb Hemost
Springborn S, Judd S, Morateck P, VanderZee D, Kidwell A, Brzezinski C, Cox A, Sather S, Neeves KB, DeRyckere D, Di Paola J, Graham DK, Branchford BR.   +12 more
europepmc   +1 more source

Influence of Previous Coronary Artery Bypass Grafting on Clinical Outcomes After Percutaneous Coronary Intervention: A Meta-Analysis of 250 684 Patients. [PDF]

Clin Med Insights Cardiol
Larik MO, Ahmed A, Shahid AR, Irfan H, Irfan A, Jibran M.   +5 more
europepmc   +1 more source

Predictive factors for long-term survival after a platelet glycoprotein IIb/IIIa receptor blocker(Abciximab; ReoPro$^{\circledR}$) in patients undergoing high-risk percutaneous coronary intervention in acute myocardial infarction

, 2003
Weon Kim, Eun-A Chung, Myung Ho Jeong, Jihyun Lim, Han-Gyun Kim, Hyung Wook Park, Young-Joon Hong, Ok-Young Park, Ju Han Kim, Youngkeun Ahn, Jeong-Gwan Cho, Jong-Chun Park, Jung-Chaee Kang   +12 more
openalex   +1 more source